Destiny Pharma Share Discussion Threads

[xcap1] 06/2/2024 09:16

Patience boys, we will get there

[xcap1] 06/2/2024 09:13

Great entry point

[carlisle44] 06/2/2024 08:47

Wow is that blue I see... about time!

[brooko19] 05/2/2024 22:17

Bones your just hoping it falls back to 30p today was your chance! Overhyped and expensive lol

[bones698] 05/2/2024 22:01

Still think wil continue to fall back to 30p range as no news coming for a while and gap to fill . Bad week but it looked overhyped and expensive at this stage . Lots of followers getting carried away and needs to breakeven asap

[ttlance] 05/2/2024 15:31

Jh I didn’t mention the milestone payment was incorporated into the cash run way. If they had received a milestone payment then this would have extended the cash run way from Q1 25.

The fact is they have always raised funds 6 months prior to cash run out, that is a known fact, there is no speculation around that statement.

I just think something isn’t right here, they have been in discussions now for 16 months for XF-73. There was a lot of expectation of M3 providing a significant milestone payment that didn’t materialise, the same could happen with XF73, the longer negotiations are drawn out the more likely that this will be the same scenario.

Don’t forget destiny spent a significant sum on a report that put the new market size in the US to $2b. This was done to try and convince partners of its potential as it wasn’t initially attractive.

[john henry] 05/2/2024 14:36

TTLance no company would guide on cash runaway and include potential milestone payments. Your making a mountain out of a mole hill, maybe instead talk about the upcoming XF73 nasal JV deal

[john henry] 05/2/2024 14:33

Candid on LSE


The RNS was indeed positive but some may have perceived the possibility of a bridging phase 2 trial by Sebela as a delay. This might not even happen as the RNS stated that Sebela are evaluating it and MAY decide to run a bridging phase 2 before doing the phase 3. I think they might in fact evaluate it and then go into phase 3 after doing a simple test to show equivalence as there is already an FDA agreement in place for exactly this reason. (DEST presentation 2023):

Process development ongoing to produce oral capsule product for Phase 3

— FDA agreed to simple disintegration test to demonstrate equivalence

between Phase 2 and Phase 3 product

— Expected to have capsules ready for Phase 3 H2 2023


Therefore Sebela may only need to before a simple test to demonstrate equivalence and M3 is back on track.
Dest having been working on an oral capsule for months.

[ttlance] 05/2/2024 14:18

Eva, absolutely correct regarding the funding. I keep seeing posters say they have enough cash until Q1 25, which is correct but all of the fund raises have been 6 months prior to cash run out. That is the case for all listed companies unless they are in dire straits and they agree to last minute funding but this only occurs with companies when they are on their knees. I wouldn’t put destiny in this bracket so expecting a fund raise in august.

This share price weakness is all about cash uncertainty, now we are certain there will be no mile stone payment from Sebela before August.

[marvelman] 05/2/2024 12:44

Just saying Eva

[eva_1989] 05/2/2024 12:38

mm - dont want to be a keyboard warrior.. Just too old now

it wont help me neither you..

let's stick to objective please

[marvelman] 05/2/2024 11:52

Eva...its still 30% higher than when you sold for your 5%. Never heard a word from you all the time it was climbing to 80p

[eva_1989] 05/2/2024 11:40

Where is sicilian_kan ?

He is the best and always put good comment here...

[john henry] 05/2/2024 10:32

There was an initial 120k plus shares dumped in the first hr which caused sharp mark down.
Since then its been all buys with very little sign of the large sells
In fact a few large delayed buys now being printed.

[marvelman] 05/2/2024 10:12

JH...thanks...I did not know that and that is reassuring.

[marvelman] 05/2/2024 10:10

I should add that I totally agree with JH that the large and consistent seller could also be the reason. At the end of the day we are the last to know as mere PI's.

[henley2] 05/2/2024 10:08

Does the news of the reformulation delay any license agreement outside the USA for NTCD-M3? Probably.
Continued radio silence from the CEO not helping.
Share price collapse means going it alone with XF73 has suddenly become more expensive in terms of dilution and companies we are speaking with will know that our negotiating position has weakened considerably since last Wednesday. Time for the CEO to break his radio silence!

[john henry] 05/2/2024 10:06

Marvelman i guess you havent considered that the cash runway until Q1 2025 does not include stage payments from Sebela.
XF73 nasal JV will more than likely include an upfront payment extending that runway.

[marvelman] 05/2/2024 09:52

Well its a possibility at the very least that, given no stage payments in the near term from Sebela, a fundraise is not out of the question.

[carlisle44] 05/2/2024 09:45

marvelman can you elaborate?

[john henry] 05/2/2024 09:39

These also SFA on offer

[john henry] 05/2/2024 09:34

Carlise44 the sharp fall imho is the large seller finally clearing out which has triggered a lot of stops.
When this unwinding of stock is complete, fundamental buyers will be all over this.

Aimho

[marvelman] 05/2/2024 09:30

The worry is Carlisle that they do know the reason for the sharp fall. I am beginning to think I do too.

[carlisle44] 05/2/2024 09:25

Is it time for the company to issue a reverse speeding ticket style announcement along the lines of : " We know of no reason for the sharp fall in share price ...."

Thought the fall would have halted by now.